chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 1 dose of Moderna COVID 19 vaccine given to a patient who is 17 years old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1 dose of Moderna COVID 19 vaccine given to a patient who is 17 years old) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1 dose of Moderna COVID 19 vaccine given to a patient who is 17 years old). On 17-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1 dose of Moderna COVID 19 vaccine given to a patient who is 17 years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Myalgia, Pain in extremity
Clinical narrative: Soreness of arm; Fever; Body aches; Headache; Heart beat increased to 80-100 beats per minute; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm), HEART RATE INCREASED (Heart beat increased to 80-100 beats per minute), PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Headache) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     Concomitant products included BIOTIN for an unknown indication.    On 17-Aug-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, the patient experienced HEART RATE INCREASED (Heart beat increased to 80-100 beats per minute). On 18-Aug-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm), PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Soreness of arm), HEART RATE INCREASED (Heart beat increased to 80-100 beats per minute), PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Aug-2021, Heart rate: 80-100 (High) Fast heart beat around 6-7 PM 80-100 beats per minute. On an unknown date, Heart rate: 75-80 (normal) 75-80 beats per minute.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs includes Birth Control     No Treatment information was reported.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Soreness of arm; Fever; Body aches; Headache; Heart beat increased to 80-100 beats per minute; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm), HEART RATE INCREASED (Heart beat increased to 80-100 beats per minute), PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Headache) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     Concomitant products included BIOTIN for an unknown indication.    On 17-Aug-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, the patient experienced HEART RATE INCREASED (Heart beat increased to 80-100 beats per minute). On 18-Aug-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm), PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Soreness of arm), HEART RATE INCREASED (Heart beat increased to 80-100 beats per minute), PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Aug-2021, Heart rate: 80-100 (High) Fast heart beat around 6-7 PM 80-100 beats per minute. On an unknown date, Heart rate: 75-80 (normal) 75-80 beats per minute.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs includes Birth Control     No Treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain
Clinical narrative: very painful; swelling of the lymphoid; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (very painful) and LYMPHADENOPATHY (swelling of the lymphoid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (very painful) and LYMPHADENOPATHY (swelling of the lymphoid). At the time of the report, PAIN (very painful) and LYMPHADENOPATHY (swelling of the lymphoid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Never received the second dose and it's been more than 36 days since the first; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Never received the second dose and it's been more than 36 days since the first) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Never received the second dose and it's been more than 36 days since the first). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Never received the second dose and it's been more than 36 days since the first) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Follow-up information included update of reporter details.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 2nd dose not received between day 25-35 of the 1st dose/COVID 19 vaccine about 3 months ago/ Patient didn't receive 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose not received between day 25-35 of the 1st dose/COVID 19 vaccine about 3 months ago/ Patient didn't receive 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose not received between day 25-35 of the 1st dose/COVID 19 vaccine about 3 months ago/ Patient didn't receive 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd dose not received between day 25-35 of the 1st dose/COVID 19 vaccine about 3 months ago/ Patient didn't receive 2nd dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The concomitant medications were not reported. The treatment information was not provided. It was reported that patient wanted to get the second dose now. And the first dose was received two to three months before. Most recent FOLLOW-UP information incorporated above includes: On 20-Aug-2021: Follow-up information included addition of additional reporter. On 23-Aug-2021: Follow-up received included additional reported details.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Do you expect the Moderna booster to have side effects similar to the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Do you expect the Moderna booster to have side effects similar to the second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Do you expect the Moderna booster to have side effects similar to the second dose). At the time of the report, VACCINATION COMPLICATION (Do you expect the Moderna booster to have side effects similar to the second dose) outcome was unknown.            the treatment history was not reported.  The concomitant medication was not reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: I have completed your on-line reporting form.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT. At the time of the report, ADVERSE EVENT outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Vaccination complication
Clinical narrative: Reactions were even more significant than the first two doses; Bone pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reactions were even more significant than the first two doses) and BONE PAIN (Bone pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised (Severely immunocompromised).    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reactions were even more significant than the first two doses) and BONE PAIN (Bone pain). At the time of the report, VACCINATION COMPLICATION (Reactions were even more significant than the first two doses) and BONE PAIN (Bone pain) outcome was unknown.            No concomitant medications provided.  No treatment medications provided.  Patient was severely immunocompromised who received 3rd dose of Moderna COVID-19 vaccine. The reactions were even more significant than first two doses as patient has bone pain now.   Reporter did not allow further contact
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Malaise
Clinical narrative: General feelings of malaise and spent a day in bed; Patient had taken 3rd dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (General feelings of malaise and spent a day in bed) and EXTRA DOSE ADMINISTERED (Patient had taken 3rd dose of the vaccine) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 054C21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (General feelings of malaise and spent a day in bed) and EXTRA DOSE ADMINISTERED (Patient had taken 3rd dose of the vaccine). At the time of the report, MALAISE (General feelings of malaise and spent a day in bed) outcome was unknown and EXTRA DOSE ADMINISTERED (Patient had taken 3rd dose of the vaccine) had resolved. No concomitant medications are reported by reporter. No treatment medications are reported by reporter. This case was linked to MOD-2021-290368.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Getting infected with COVID; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Getting infected with COVID) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Getting infected with COVID). At the time of the report, COVID-19 (Getting infected with COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medication were reported. The reporter states that people who have received the COVID-19 vaccine in her area are getting infected with COVID-19.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dysgeusia, Myalgia, Rhinorrhoea, SARS-CoV-2 antibody test
Clinical narrative: Bitterness; Runny nose; Joint pain; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA, RHINORRHOEA, ARTHRALGIA, and MYALGIA in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A211A and 001C21A) for COVID-19 vaccination.     The patient's past medical history included Sleep apnea. Concurrent medical conditions included Type 2 diabetes mellitus, Blood pressure high, and Allergy. Concomitant products included METFORMIN, OMEPRAZOLE, METOPROLOL, ATORVASTATIN, GLIPIZIDE, and LOSARTAN/HYDROCHLOORTHIAZIDE for an unknown indication.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA, RHINORRHOEA, ARTHRALGIA, and MYALGIA. At the time of the report, DYSGEUSIA, RHINORRHOEA, ARTHRALGIA, and MYALGIA outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test positive antibodies test for covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported by patient.  Patient reported that he got the Moderna covid-19 vaccine and some time later he got a positive antibodies test for covid-19, doctor suggested that might need to change the statin because it might be the culprit.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Illness, Myalgia
Clinical narrative: Sickness; Tachycardia; Pain; Dizziness; Fever; Chills; a lot of muscle pain after the second dose of the vaccine; Arthralgia; This spontaneous case was reported by a pharmacist and describes the occurrence of ILLNESS (Sickness), TACHYCARDIA (Tachycardia), PAIN (Pain), DIZZINESS (Dizziness) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sickness), TACHYCARDIA (Tachycardia), PAIN (Pain), DIZZINESS (Dizziness), PYREXIA (Fever), CHILLS (Chills), MYALGIA (a lot of muscle pain after the second dose of the vaccine) and ARTHRALGIA (Arthralgia). At the time of the report, ILLNESS (Sickness), TACHYCARDIA (Tachycardia), PAIN (Pain), DIZZINESS (Dizziness), PYREXIA (Fever), CHILLS (Chills), MYALGIA (a lot of muscle pain after the second dose of the vaccine) and ARTHRALGIA (Arthralgia) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Follow-up received on 18 Aug 2021, Added events.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Tachycardia
Clinical narrative: Sickness; Tachycardia; Pain; Dizziness; Fever; Chills; a lot of muscle pain after the second dose of the vaccine; Arthralgia; This spontaneous case was reported by a pharmacist and describes the occurrence of ILLNESS (Sickness), TACHYCARDIA (Tachycardia), PAIN (Pain), DIZZINESS (Dizziness) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sickness), TACHYCARDIA (Tachycardia), PAIN (Pain), DIZZINESS (Dizziness), PYREXIA (Fever), CHILLS (Chills), MYALGIA (a lot of muscle pain after the second dose of the vaccine) and ARTHRALGIA (Arthralgia). At the time of the report, ILLNESS (Sickness), TACHYCARDIA (Tachycardia), PAIN (Pain), DIZZINESS (Dizziness), PYREXIA (Fever), CHILLS (Chills), MYALGIA (a lot of muscle pain after the second dose of the vaccine) and ARTHRALGIA (Arthralgia) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Follow-up received on 18 Aug 2021, Added events.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Product dose omission issue
Clinical narrative: cannot get the 2nd shot; 17 year old patient was given the 1st shot of the Moderna vaccine in April/erroneously given the first shot of the Moderna vaccine/under 18 child was erroneously given the first shot of; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was given the 1st shot of the Moderna vaccine in April/erroneously given the first shot of the Moderna vaccine/under 18 child was erroneously given the first shot of) and PRODUCT DOSE OMISSION ISSUE (cannot get the 2nd shot) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was given the 1st shot of the Moderna vaccine in April/erroneously given the first shot of the Moderna vaccine/under 18 child was erroneously given the first shot of). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (cannot get the 2nd shot). On 03-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was given the 1st shot of the Moderna vaccine in April/erroneously given the first shot of the Moderna vaccine/under 18 child was erroneously given the first shot of) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (cannot get the 2nd shot) had resolved.            Caller says her underage son received 1st dose and now cannot get his 2nd dose . She enquires what are the options at this point. She also states he does not take any medication regularly.   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Non-Significant Follow up appended On 18-Aug-2021: Non significant Follow-up appended On 18-Aug-2021: Significant followup ; outcome of event updated to recovered and added reporters address
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant when vaccinated,Are you still looking for pregnant women who have been vaccinated; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant when vaccinated,Are you still looking for pregnant women who have been vaccinated) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant when vaccinated,Are you still looking for pregnant women who have been vaccinated). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant when vaccinated,Are you still looking for pregnant women who have been vaccinated) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient's last cycle was in November.  No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Follow-up received on 18 Aug 2021 included no new information.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Eight days after I received my first Moderna shot my arm started itching at the shot ssite; Get red where you got the shot eight days later; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Eight days after I received my first Moderna shot my arm started itching at the shot ssite) and VACCINATION SITE ERYTHEMA (Get red where you got the shot eight days later) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Eight days after I received my first Moderna shot my arm started itching at the shot ssite) and VACCINATION SITE ERYTHEMA (Get red where you got the shot eight days later). At the time of the report, VACCINATION SITE PRURITUS (Eight days after I received my first Moderna shot my arm started itching at the shot ssite) and VACCINATION SITE ERYTHEMA (Get red where you got the shot eight days later) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.    No treatment medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint Pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint Pain) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 031A211A) for COVID-19 vaccination.     Concurrent medical conditions included Immunosuppression. Concomitant products included METFORMIN, OMEPRAZOLE (OMEPRAZOLE ABBOTT), HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN + HIDROCLOROTIAZIDA), METOPROLOL, ATORVASTATIN and GLIPIZIDE for an unknown indication.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint Pain). At the time of the report, ARTHRALGIA (Joint Pain) outcome was unknown.            Treatment information was not provided.   This case was linked to MOD-2021-292622 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: had a fever of 99 F that lasted the rest of the day; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (had a fever of 99 F that lasted the rest of the day) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. # 010M20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (had a fever of 99 F that lasted the rest of the day). At the time of the report, PYREXIA (had a fever of 99 F that lasted the rest of the day) had resolved.            No concomitant medications were provided by reporter. No treatment details were provided by reporter.   This case was linked to MOD-2021-290618 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis acneiform, Myalgia, Rash erythematous
Clinical narrative: rash /more red; Rashes are more like a little pimples; arm kind of hurts; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH ERYTHEMATOUS (rash /more red), DERMATITIS ACNEIFORM (Rashes are more like a little pimples) and MYALGIA (arm kind of hurts) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (rash /more red), DERMATITIS ACNEIFORM (Rashes are more like a little pimples) and MYALGIA (arm kind of hurts). At the time of the report, RASH ERYTHEMATOUS (rash /more red), DERMATITIS ACNEIFORM (Rashes are more like a little pimples) and MYALGIA (arm kind of hurts) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medication was not provided treatment information was not provided
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: fully vaccinated but contracted Covid about 1 week ago; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (fully vaccinated but contracted Covid about 1 week ago) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (fully vaccinated but contracted Covid about 1 week ago). At the time of the report, COVID-19 (fully vaccinated but contracted Covid about 1 week ago) outcome was unknown.            No Concomitant medications were provided.  No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Follow-up information included no new information.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The treatment information was unknown.   Reporter did not allow further contact
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Myalgia, Pain, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurt), PAIN (pain spread across the chest, mostly over the left breast area), INFLAMMATION (pain feels muscular and inflamed) and MYALGIA (the pain feels muscular) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 046B21A) for COVID-19 vaccination. Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S), PREGABALIN, PREDNISONE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE (CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]), CELECOXIB (CELEBREX), CYANOCOBALAMINE, BELIMUMAB, LANSOPRAZOLE, IRON and RIBOFLAVIN for an unknown indication. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (left arm hurt), PAIN (pain spread across the chest, mostly over the left breast area), INFLAMMATION (pain feels muscular and inflamed) and MYALGIA (the pain feels muscular). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (left arm hurt) had resolved and PAIN (pain spread across the chest, mostly over the left breast area), INFLAMMATION (pain feels muscular and inflamed) and MYALGIA (the pain feels muscular) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient described the pain feels muscular and inflamed and has spread across the chest, mostly over the left breast area. The patient explained they have Lupus and are on a lot of immunosuppressing medications. This case was linked to MOD-2021-290995.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Erythema, Feeling hot, Peripheral swelling
Clinical narrative: COVID Arm (from left Shoulder to elbow); Swollen (from left Shoulder to elbow) after second shot; Red (from left Shoulder to elbow) after second shot; Hot to the touch (from left Shoulder to elbow) after second shot; Rash (from left Shoulder to elbow) after second shot; Fever 101 F after second shot; Chills after second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID Arm (from left Shoulder to elbow)), PERIPHERAL SWELLING (Swollen (from left Shoulder to elbow) after second shot), ERYTHEMA (Red (from left Shoulder to elbow) after second shot), FEELING HOT (Hot to the touch (from left Shoulder to elbow) after second shot) and RASH (Rash (from left Shoulder to elbow) after second shot) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced PYREXIA (Fever 101 F after second shot) and CHILLS (Chills after second shot). On 17-Mar-2021, the patient experienced VACCINATION COMPLICATION (COVID Arm (from left Shoulder to elbow)), PERIPHERAL SWELLING (Swollen (from left Shoulder to elbow) after second shot), ERYTHEMA (Red (from left Shoulder to elbow) after second shot), FEELING HOT (Hot to the touch (from left Shoulder to elbow) after second shot) and RASH (Rash (from left Shoulder to elbow) after second shot). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 17-Mar-2021, PYREXIA (Fever 101 F after second shot) and CHILLS (Chills after second shot) had resolved. On 18-Mar-2021, PERIPHERAL SWELLING (Swollen (from left Shoulder to elbow) after second shot), ERYTHEMA (Red (from left Shoulder to elbow) after second shot) and FEELING HOT (Hot to the touch (from left Shoulder to elbow) after second shot) had resolved. On 31-Mar-2021, VACCINATION COMPLICATION (COVID Arm (from left Shoulder to elbow)) and RASH (Rash (from left Shoulder to elbow) after second shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 101 (High) She also had fever 101 F..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  She has not reported to VAERS.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Vaccination complication
Clinical narrative: COVID Arm (from left Shoulder to elbow); Swollen (from left Shoulder to elbow) after second shot; Red (from left Shoulder to elbow) after second shot; Hot to the touch (from left Shoulder to elbow) after second shot; Rash (from left Shoulder to elbow) after second shot; Fever 101 F after second shot; Chills after second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID Arm (from left Shoulder to elbow)), PERIPHERAL SWELLING (Swollen (from left Shoulder to elbow) after second shot), ERYTHEMA (Red (from left Shoulder to elbow) after second shot), FEELING HOT (Hot to the touch (from left Shoulder to elbow) after second shot) and RASH (Rash (from left Shoulder to elbow) after second shot) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced PYREXIA (Fever 101 F after second shot) and CHILLS (Chills after second shot). On 17-Mar-2021, the patient experienced VACCINATION COMPLICATION (COVID Arm (from left Shoulder to elbow)), PERIPHERAL SWELLING (Swollen (from left Shoulder to elbow) after second shot), ERYTHEMA (Red (from left Shoulder to elbow) after second shot), FEELING HOT (Hot to the touch (from left Shoulder to elbow) after second shot) and RASH (Rash (from left Shoulder to elbow) after second shot). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 17-Mar-2021, PYREXIA (Fever 101 F after second shot) and CHILLS (Chills after second shot) had resolved. On 18-Mar-2021, PERIPHERAL SWELLING (Swollen (from left Shoulder to elbow) after second shot), ERYTHEMA (Red (from left Shoulder to elbow) after second shot) and FEELING HOT (Hot to the touch (from left Shoulder to elbow) after second shot) had resolved. On 31-Mar-2021, VACCINATION COMPLICATION (COVID Arm (from left Shoulder to elbow)) and RASH (Rash (from left Shoulder to elbow) after second shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 101 (High) She also had fever 101 F..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  She has not reported to VAERS.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: first dose 35 days ago; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose 35 days ago) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose 35 days ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first dose 35 days ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not reported. Nurse has called that the patient who is trying to get the second dose outside of the recommended time frame.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity
Clinical narrative: arm pain; muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), MYALGIA (muscle pain) and HEADACHE (Headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A and 006021A) for COVID-19 vaccination.     Concomitant products included METFORMIN, ACETYLSALICYLIC ACID (ASPIRIN 1000) and ATORVASTATIN for an unknown indication.   On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Aug-2021, the patient experienced PAIN IN EXTREMITY (arm pain), MYALGIA (muscle pain) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (arm pain), MYALGIA (muscle pain) and HEADACHE (Headache) outcome was unknown.            Treatment medications were not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Less than 25 days between the first and second shot; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 25 days between the first and second shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 25 days between the first and second shot). On 09-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 25 days between the first and second shot) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Developed shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Developed shortness of breath) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Developed shortness of breath). At the time of the report, DYSPNOEA (Developed shortness of breath) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient developed shortness of breath after first dose of vaccination, which lasted approximately 5 days.  The patient used rescue inhaler for relieving the symptom.  No concomitant medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain
Clinical narrative: had little pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (had little pain at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included Cancer and Back pain.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced VACCINATION SITE PAIN (had little pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-May-2021, VACCINATION SITE PAIN (had little pain at the injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.   This case was linked to MOD-2021-290939 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Feeling abnormal, Hypokinesia, Malaise, Pain
Clinical narrative: she experienced pain; felt horrible / felt terrible; felt sick; could not eat or drink; could not even move to use the restroom; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (she experienced pain), FEELING ABNORMAL (felt horrible / felt terrible), MALAISE (felt sick), FEEDING DISORDER (could not eat or drink) and HYPOKINESIA (could not even move to use the restroom) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cancer. Concurrent medical conditions included Back pain.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced PAIN (she experienced pain), FEELING ABNORMAL (felt horrible / felt terrible), MALAISE (felt sick), FEEDING DISORDER (could not eat or drink), HYPOKINESIA (could not even move to use the restroom) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (she experienced pain), FEELING ABNORMAL (felt horrible / felt terrible), MALAISE (felt sick), FEEDING DISORDER (could not eat or drink), HYPOKINESIA (could not even move to use the restroom) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) COVID-19 virus test was negative.         No concomitant medications was provided. It was reported that the adverse events lasted few days 2 to 3 days. Consumer states that because she was taking Tylenol, she could not take her back-pain medications.   This case was linked to MOD-2021-290917 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: she experienced pain; felt horrible / felt terrible; felt sick; could not eat or drink; could not even move to use the restroom; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (she experienced pain), FEELING ABNORMAL (felt horrible / felt terrible), MALAISE (felt sick), FEEDING DISORDER (could not eat or drink) and HYPOKINESIA (could not even move to use the restroom) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cancer. Concurrent medical conditions included Back pain.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced PAIN (she experienced pain), FEELING ABNORMAL (felt horrible / felt terrible), MALAISE (felt sick), FEEDING DISORDER (could not eat or drink), HYPOKINESIA (could not even move to use the restroom) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (she experienced pain), FEELING ABNORMAL (felt horrible / felt terrible), MALAISE (felt sick), FEEDING DISORDER (could not eat or drink), HYPOKINESIA (could not even move to use the restroom) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) COVID-19 virus test was negative.         No concomitant medications was provided. It was reported that the adverse events lasted few days 2 to 3 days. Consumer states that because she was taking Tylenol, she could not take her back-pain medications.   This case was linked to MOD-2021-290917 (Patient Link).